000 | 01934 a2200553 4500 | ||
---|---|---|---|
005 | 20250516200138.0 | ||
264 | 0 | _c20140605 | |
008 | 201406s 0 0 eng d | ||
022 | _a1544-0591 | ||
024 | 7 |
_a10.1177/0022034514523785 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChang, P-C | |
245 | 0 | 0 |
_aSoft-tissue wound healing by anti-advanced glycation end-products agents. _h[electronic resource] |
260 |
_bJournal of dental research _cApr 2014 |
||
300 |
_a388-93 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAlveolar Process _xdrug effects |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCell Adhesion Molecules |
650 | 0 | 4 |
_aCicatrix _xpathology |
650 | 0 | 4 |
_aCollagen _xdrug effects |
650 | 0 | 4 |
_aCollagen Type I _xanalysis |
650 | 0 | 4 | _aDown-Regulation |
650 | 0 | 4 |
_aFibronectins _xanalysis |
650 | 0 | 4 |
_aGlycation End Products, Advanced _xanalysis |
650 | 0 | 4 |
_aGuanidines _xpharmacology |
650 | 0 | 4 |
_aHeme Oxygenase (Decyclizing) _xanalysis |
650 | 0 | 4 | _aInflammation |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
650 | 0 | 4 |
_aPalate _xdrug effects |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aRe-Epithelialization _xdrug effects |
650 | 0 | 4 | _aReceptor for Advanced Glycation End Products |
650 | 0 | 4 |
_aReceptors, Immunologic _xanalysis |
650 | 0 | 4 |
_aThiazoles _xpharmacology |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xanalysis |
650 | 0 | 4 | _aVascular Endothelial Growth Factor A |
650 | 0 | 4 | _aWound Closure Techniques |
650 | 0 | 4 |
_aWound Healing _xdrug effects |
700 | 1 | _aTsai, S-C | |
700 | 1 | _aJheng, Y-H | |
700 | 1 | _aLin, Y-F | |
700 | 1 | _aChen, C-C | |
773 | 0 |
_tJournal of dental research _gvol. 93 _gno. 4 _gp. 388-93 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/0022034514523785 _zAvailable from publisher's website |
999 |
_c23571863 _d23571863 |